We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+13.06%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$8.1B
AUM Growth
+$4.9B
Cap. Flow
+$4.22B
Cap. Flow %
52.11%
Top 10 Hldgs %
26.76%
Holding
6,444
New
505
Increased
3,426
Reduced
1,637
Closed
524

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$314M
2
AAPL icon
Apple
AAPL
+$247M
3
MSFT icon
Microsoft
MSFT
+$235M
4
AMZN icon
Amazon
AMZN
+$110M
5
NVDA icon
NVIDIA
NVDA
+$99M

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$21.7M
2
VNQ icon
Vanguard Real Estate ETF
VNQ
+$13.8M
3
SPLV icon
Invesco S&P 500 Low Volatility ETF
SPLV
+$12.8M
4
USO icon
United States Oil Fund
USO
+$12.5M
5
IBB icon
iShares Biotechnology ETF
IBB
+$12M

Sector Composition

Rank Sector Weight
1 Technology 26.14%
2 Financials 11.29%
3 Healthcare 10.69%
4 Consumer Discretionary 10.28%
5 Industrials 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTCT icon
2176
PTC Therapeutics
PTCT
$6.02B
$183K ﹤0.01%
6,648
+4,272
+180% +$97.7K
SPCE icon
2177
Virgin Galactic
SPCE
$474M
$183K ﹤0.01%
3,733
+2,353
+171% +$92.9K
HAFC icon
2178
Hanmi Financial
HAFC
$959M
$183K ﹤0.01%
9,412
+4,925
+110% +$82.9K
PRTA icon
2179
Prothena Corp
PRTA
$471M
$182K ﹤0.01%
5,019
+3,621
+259% +$139K
OII icon
2180
Oceaneering
OII
$5.13B
$182K ﹤0.01%
8,570
-194
-2% -$4.3K
AMK
2181
DELISTED
AssetMark Financial Holdings, Inc.
AMK
$182K ﹤0.01%
6,085
+5,827
+2,259% +$150K
ITOS
2182
DELISTED
iTeos Therapeutics
ITOS
$182K ﹤0.01%
16,637
+13,989
+528% +$139K
CTO
2183
CTO Realty Growth
CTO
$822M
$181K ﹤0.01%
10,470
+8,880
+558% +$148K
AMLX icon
2184
Amylyx Pharmaceuticals
AMLX
$2.52B
$181K ﹤0.01%
12,314
+8,343
+210% +$128K
AZEK
2185
DELISTED
The AZEK Co
AZEK
$181K ﹤0.01%
4,722
+4,596
+3,648% +$143K
KNSA icon
2186
Kiniksa Pharmaceuticals
KNSA
$6.04B
$181K ﹤0.01%
10,292
+9,008
+702% +$148K
ASC icon
2187
Ardmore Shipping
ASC
$708M
$180K ﹤0.01%
12,792
+8,171
+177% +$110K
OSBC icon
2188
Old Second Bancorp
OSBC
$1.31B
$180K ﹤0.01%
11,673
+1,236
+12% +$17.9K
STC icon
2189
Stewart Information Services
STC
$2.05B
$180K ﹤0.01%
3,067
+1,359
+80% +$64.5K
DCO icon
2190
Ducommun
DCO
$3.02B
$179K ﹤0.01%
3,447
+3,241
+1,573% +$158K
DEI icon
2191
Douglas Emmett
DEI
$1.99B
$179K ﹤0.01%
12,331
-4,704
-28% -$59.7K
MLNK
2192
DELISTED
MeridianLink
MLNK
$179K ﹤0.01%
7,208
-52
-0.7% -$1.01K
CGDV icon
2193
Capital Group Dividend Value ETF
CGDV
$39.1B
$179K ﹤0.01%
5,983
-11,485
-66% -$317K
OGN icon
2194
Organon & Co
OGN
$3.6B
$178K ﹤0.01%
12,371
-14,531
-54% -$198K
DOO
2195
Bombardier Recreational Products
DOO
$4.77B
$178K ﹤0.01%
2,489
-2,458
-50% -$172K
OSG
2196
Octave Specialty Group
OSG
$211M
$178K ﹤0.01%
10,809
-6,555
-38% -$91.1K
BASE
2197
DELISTED
Couchbase
BASE
$178K ﹤0.01%
7,907
+7,665
+3,167% +$140K
ZYME icon
2198
Zymeworks
ZYME
$1.83B
$178K ﹤0.01%
17,092
+14,612
+589% +$116K
ADTN icon
2199
Adtran
ADTN
$667M
$178K ﹤0.01%
24,187
+20,141
+498% +$133K
NGD
2200
DELISTED
New Gold Inc
NGD
$177K ﹤0.01%
121,553
+96,072
+377% +$121K
86 87
88
89 90

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2023 Portfolio in Review

As of Q4 2023, Tower Research Capital (TRC) held 6,444 positions worth $8.1B, up 153% from $3.2B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $4.22B of net new capital in Q4 2023, opening 505 new positions and adding to 3,426 existing holdings. Its largest new stake was Veralto: 28,523 shares worth $2.35M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $21.7M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2023 buy was Veralto: 28,523 shares worth $2.35M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $314M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2023 reduction was iShares MSCI EAFE ETF, cutting an estimated $21.7M.
  • Tower Research Capital (TRC) fully exited Vanguard Morningstar Total Stock Market ETF in Q4 2023, selling an estimated $6.02M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $8.1B portfolio in Q4 2023.
  • Tower Research Capital (TRC) opened 505 new positions and closed 524 in Q4 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 153% quarter-over-quarter to $8.1B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.